State Ledger
Company profile

GT Biopharma, Inc. CIK 109657

Ticker
GTBP (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Francisco, CA 94111
Fiscal year end
2025 (FY)
Market Data
Close
$6.87
Change
+$0.38
Change %
5.86%
Volume
721

GTBP · trading date Oct 12, 2026 · previous close $6.49 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$28.35M
Total assets
$8.11M
Total liabilities
—
Stockholders' equity
$5.79M
Cash & equivalents
$6.81M
Operating income
-$12.42M
Operating cash flow
-$12.91M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-02. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
71.4%
CapEx / revenue
—
Operating cash flow / net income
0.46×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$28.35M $8.11M — $5.79M
2024 — -$13.16M $4.23M — -$1.67M
2023 — -$7.60M $14.11M $6.63M $7.48M
2022 — -$20.88M $16.74M $5.00M $11.73M
2021 — -$58.01M $32.17M $10.26M $21.91M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SCHEDULE 13G
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-02

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
San Francisco, CA 94111
505 MONTGOMERY STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies